Skip to main navigation Skip to search Skip to main content

Uncommon BCR-ABL kinase domain mutations in kinase inhibitor-resistant chronic myelogenous leukemia and Ph+ acute lymphoblastic leukemia show high rates of regression, suggesting weak selective effects

  • Dan Jones
  • , Su S. Chen
  • , Elias Jabbour
  • , Mary Beth Rios
  • , Hagop Kantarjian
  • , Jorge Cortes

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)5428-5429
Number of pages2
JournalBlood
Volume115
Issue number26
DOIs
StatePublished - Jul 1 2010
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this